CJC-1295

growth hormone

CJC-1295 (with or without DAC)

Mechanism of Action

A synthetic GHRH analog that stimulates the pituitary gland to produce growth hormone in a pulsatile pattern. Often stacked with Ipamorelin for synergistic GH release.

Common Doses

100mcg

1x daily before bedsubcutaneous

1mg

1x weekly (with DAC)subcutaneous

Common Protocols

CJC + Ipamorelin Stack8-12 weeks

CJC-1295 (no DAC) 100mcg + Ipamorelin 200mcg before bed

Safety Notes

May cause water retention, tingling, flushing, or headache. Can affect blood sugar levels. Not FDA-approved.

Legal Status

United States

Category 1 (pending)

Australia

Schedule 4

United Kingdom

Unregulated (RUO)

Ready to track this peptide?

Start Experiment

This information is for educational purposes only. N1X does not recommend, endorse, or facilitate access to any substance. Always consult a qualified healthcare provider before starting any protocol.